Radiotherapy Market to Hit USD 9.62 Billion by 2030 with 4.9% CAGR | MarketsandMarkets - Seite 2

The significant target patient population, untapped opportunities, and low competition in developing economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the radiotherapy market.

Based on the system, software & service, radiotherapy market is segmented into system and software & service. During the forecast period, system is expected to dominate the radiotherapy market. The rising usage of automated radiotherapy systems among cancer facilities is one of the major factors after the growing number of cancer cases for the adoption of the system. Furthermore, the growth of the system segment will be driven by increase in industry adoption of radiotherapy products.

Based on procedure, the radiotherapy market is segmented into external beam radiotherapy procedures and internal beam radiotherapy procedures/brachytherapy. The EBRT is further divided into Intensity modulated radiotherapy (IMRT), Image guided radiotherapy (IGRT), 3D Conformal radiotherapy (3D-CRT), Stereotactic radiotherapy (SRT), Particle therapy and others. Meanwhile, the IBRT/brachytherapy is further divided into LDR brachytherapy, HDR brachytherapy and PDR brachytherapy. Throughout the forecast period, the EBRT segment is projected to claim the leading position in the market. The primary growth drivers include the reduced risk of radiation exposure in EBRT and the increased precision & accuracy of tumor targeting.

Based on application, the radiotherapy market is segmented into external beam radiotherapy (EBRT) applications and internal beam radiotherapy (IBRT)/brachytherapy applications. During the forecast period, the external beam radiotherapy (EBRT) sector is poised to command the most substantial market share in the radiotherapy market. This dominance is fueled by the increasing adoption and the efficacy of EBRT for new cancer types.

The radiotherapy market covers five key geographies - North America, Europe, Asia Pacific, Latin America, and the Middle East. In 2024, the Asia-Pacific region is anticipated to present noteworthy growth prospects for radiotherapy. This expansion is credited to the rising healthcare spending, the growth of the cancer hospitals and radiotherapy sectors in India and China, and annual rise in geriatric population in several Asia Pacific countries.